Beverly Green, MD, MPH, is a physician-scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow—and easier for providers to deliver.
Dr. Green’s research has a strong public health focus, targeting conditions that affect large proportions of the population, such as cardiovascular disease, cancer, and obesity. She also emphasizes leveraging technologies and systems-based care.
In 2016 Dr. Green launched the BP-CHECK study, which aims to find the easiest, most accurate way to diagnose high blood pressure. With a $2.8 million award from the Patient-Centered Outcomes Research Institute (PCORI), the study will compare blood pressure readings taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension.
Dr. Green’s previous research has shown that:
She is now working to translate similar innovative approaches to care into community settings through collaborations with the OCHIN Practice-Based Research Network and two large health insurance plans that provide Medicaid insurance to low-income individuals and families.
She is also a core member of the Alliance for Reducing Cancer, Northwest, a collaborative team of cancer prevention and control experts and community stakeholders whose mission is build relationships between researchers and community partners, conduct cancer-related research, and translate research into community practice.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was as an associate editor for the American Journal of Preventive Medicine from 2009 to 2014. She is an editorial board member of the Journal of the American Board of Family Practice. She is also a fellow of the American Heart Association, an honor given for contributions to the field. Dr. Green has served as an associate clinical professor at the UW School of Medicine since 1992.
Meenan RT, Baldwin LM, Coronado GD, Schwartz M, Coury J, Petrik AF, West II, Green BB. Costs of two health insurance plan programs to mail fecal immunochemical tests to Medicare and Medicaid plan members. Popul Health Manag. 2021 Apr;24(2):255-265. doi: 10.1089/pop.2020.0041. Epub 2020 Jun 29. PubMed
Gupta S, Coronado GD, Argenbright K, Brenner AT, Castaneda SF, Dominitz JA, Green B, Issaka RB, Levin TR, Reuland DS, Richardson LC, Robertson DJ, Singal AG, Pignone M. Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit. CA Cancer J Clin. 2020 Jun 25. doi: 10.3322/caac.21615. [Epub ahead of print]. PubMed
Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB. Methodological considerations in calculating and analyzing proportion of time covered as a measure of longitudinal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 2020 May 28:cebp.0388.2020. doi: 10.1158/1055-9965.EPI-20-0388. [Epub ahead of print]. PubMed
Green BB, West II, Baldwin LM, Schwartz MR, Coury J, Coronado GD. Challenges in reaching Medicaid and Medicare enrollees in a mailed fecal immunochemical test program. J Community Health. 2020 Mar 26. doi: 10.1007/s10900-020-00809-9. [Epub ahead of print]. PubMed
Baldwin LM, Schneider JL, Schwartz M, Rivelli JS, Green BB, Petrik AF, Coronado GD. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders. BMC Health Serv Res. 2020 Feb 21;20(1):132. doi: 10.1186/s12913-019-4868-5. PubMed
KPWHRI’s Kilian Kimbel reflects on how the SOS study helped pave the way for a new program to find colon cancer early.
Home blood pressure monitoring shown to be an excellent alternative for making new diagnoses of hypertension.
Research led by KPWHRI’s Beverly Green, MD, MPH, finds that patients prefer at-home monitoring of blood pressure.
VeryWell Health, March 16, 2022